- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
DesAcc signs on U.K. distributor
DesAcc signs on U.K. distributorDICOM software developer DesAcc has signed a distributor agreement with Max MediTel of Cambridge, England. Max MediTel will distribute the Chicago-based firm’s DICOM software tools in the U.K.DesAcc’s
DesAcc signs on U.K. distributor
DICOM software developer DesAcc has signed a distributor agreement with Max MediTel of Cambridge, England. Max MediTel will distribute the Chicago-based firms DICOM software tools in the U.K.
DesAccs products include Digital Jacket, a PC-based personal archive that is used by over 200 different models of DICOM-compliant scanners, according to the company. Other products include low-cost DICOM plug-ins for off-the-shelf graphics software as well as libraries for OEM manufacturers.
Max MediTel serves as the systems development and sales arm of Max Medical Software, a U.K. firm that produces and markets orthopedic patient record software, 3-D cameras for surgical planning, and telemedicine systems for the U.K. National Health Service and several other European Union countries.
- Search again
- Homepage
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
